The VITAL project published an educational platform as well as a toolbox to boost vaccination uptake amongst older people.

Immunisation with life-saving vaccines is one of the greatest achievements in public health, but a growing wave of misinformation/disinformation in the wake of the COVID-19 pandemic threatens to undermine the many successes of vaccination.

This commentary highlights the potential need to incorporate neuraminidase components into future influenza vaccines

Estimates of current mid-season flu vaccine effectiveness (VE) in Europe and China range from 32% to 58% overall, with greater protection against influenza B than A, according to three studies published in Eurosurveillance.

The evolution of the antibody response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is impacted by the nature and number of antigenic exposures.

WHO announced them at the meeting on the composition of Influenza Virus Vaccines. These gatherings are held twice a year, bringing together an advisory group of experts from WHO Collaborating Centres and WHO Essential Regulatory Laboratories.

Pregnant women with COVID-19 are more likely to develop severe COVID-19 and related ill health than non-pregnant women of similar age.

Launched in Brussels on 30 January to drive political momentum for broader vaccine uptake across all stages of life. The group is co-chaired by Croatian MEP Tomislav Sokol and Lithuanian MEP Vytenis Andriukaitis, a former European Commissioner for Health.